The comorbidity–polypharmacy score (CPS) is able to quantify the magnitude of comorbid conditions using the number of co-administered medications as a measure of the “intensity” of therapy required for associated comorbidities [77]. Several studies have shown a negative association between polypharma...
The effects of Nrg-1 on OL lineage cells, as well as its ability to modulate the inflammatory response to trauma, make Nrg-1 therapy a promising direction in CNS injury research. 3.1.3. Hormones Thyroid hormone, a potent regulator of the timing of developmental OL differentiation, is also ...